Post-market validation of the Beijing Genomics Institute (BGI) SARS-CoV-2 Real Time PCR platform
This report presents the results of post-market validation of the Beijing Genomics Institute SARS-CoV-2 Real time PCR test kit.
Downloads
Post-market validation of the Beijing Genomics Institute (BGI) SARS-CoV-2 Real Time PCR platform
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Publication date:
10 June 2020
Last updated:
11 June 2020
Publication type:
Report
Intended audience:
General public
Description:
The Peter Doherty Institute for Infection and Immunity has completed a validation study of the Beijing Genomics Institute SARS-CoV-2 Real time PCR test kit and associated instrumentation and reagents.